GlassScriptPhysician profile
Vickie L Lambert
NPI 1982155057
$825.47
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.78 · 2022: $119 · 2023: $350 · 2024: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $681.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $168.41 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| United Therapeutics Corporation | $144.99 | 2023-2024 | Tyvaso |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.42 | 2023 | Ofev |
| Merck Sharp & Dohme LLC | $61.70 | 2022-2023 | Verquvo, Belsomra |
| Angiodynamics, INC. | $54.04 | 2022-2023 | Auryon Laser System 100-120 Vac |
| Janssen Pharmaceuticals, INC | $49.67 | 2023-2024 | Xarelto |
| Boston Scientific Corporation | $45.46 | 2023-2024 | Watchman Flx |
| Mylan Specialty L.P. | $44.32 | 2023 | Yupelri |
| Zimmer Biomet Holdings, INC. | $34.57 | 2021-2024 | Ribfix Blu Advantage |
| Edwards Lifesciences Corporation | $30.00 | 2022 | |
| Grifols USA, LLC | $28.00 | 2022 | |
| Abiomed | $20.82 | 2024 | Impella |
| Novo Nordisk INC | $19.28 | 2024 | Wegovy |
| Harmony Biosciences LLC | $18.61 | 2023 | Wakix |
| Glaxosmithkline, LLC. | $14.99 | 2023 | Nucala, Trelegy Ellipta |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vickie Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.